Arysta LifeScience Netherlands v. European Commission

T-476/17 R
September 4, 2017
European Union, Luxembourg

Economic stakeholders
Arysta LifeScience Netherlands
European Commission
No description

EU court
, Diflubenzuron
Suspension of the implementation of Commission Implementing Regulation (EU) 2017/855 as regards the conditions for the approval of the active substance diflubenzuron
Court of Justice of Luxembourg, European Union

June 22, 2018
The application for interim measures is dismissed.

The applicant, a manufacturer of diflubenzuron products, seeks on 27/7/2017 the annulment of Commission Implementing Regulation (EU) 2017/855 which requires Member States to amend or withdraw existing authorisations for plant protection products containing diflubenzuron by 8 September 2017 at the latest (T-476/17). Pending the judgment, the applicant lodged this summary judgment seeking to suspend the execution of the said regulation. The request is rejected.